Skip to content

The child with atopic dermatitis/food allergy and his parents: from victim to expert in the multidisciplinary team

A randomised controlled study: effects of shared medical appointments (SMAs) on parental quality of life and disease severity of children with atopic dermatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN08506572
Enrollment
140
Registered
2014-05-19
Start date
2009-11-06
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis (and food allergy within the atopic syndrome) Skin and Connective Tissue Diseases Atopic dermatitis

Interventions

1. Intervention group: three shared medical appointments in the outpatient clinic of Pediatric Dermatology UMC Utrecht 2. Control group: three face-to-face consults in the outpatient c

Sponsors

Foundation for Children's Welfare Stamps Netherlands (Stichting Kinderpostzegels Nederland) (Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Moderate or severe atopic dermatitis 2. New patient of Pediatric Dermatology Allergology Department of UMC Utrecht 3. Children up to the age of 18 4. Parents are able to speak and write in Dutch 5. Internet access and able to use the Digital Eczema Center Utrecht

Exclusion criteria

Exclusion criteria: Current participation in another study

Design outcomes

Primary

MeasureTime frame
Coping of parents, measured with a subscale of the QoLPAD All outcomes were measured at baseline, within 2 weeks after the third appointment, at 2 months and at 6 months.

Secondary

MeasureTime frame
1. Quality of life of parents, measured with the QoLPAD 2. Severity of eczema, measured with SA-EASI 3. Anxiety to corticosteroids, measured with the State Anxiety scale of the STAI 4. Trait Anxiety, measured with the Trait Anxiety scale of the STAI Only children 8 or over: 1. Coping with itch, measured with the JUCKKI-JUCKJU 2. Coping with disease, measured with the COPEKI-COPEJU All outcomes were measured at baseline, within 2 weeks after the third appointment, at 2 months and at 6 months.

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 21, 2026